Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
“We have a clear and focused commitment to accelerate oncology innovation and transform the way cancer is treated, both by leveraging our internal expertise and capabilities, and through our collaborations,”
Luciano Rossetti, Head of Research & Development at the biopharma business

Bringing innovation to patients: Our company at ASCO 2016

The annual meeting of the American Society of Clinical Oncology (ASCO – June 3-6, 2016, Chicago) features research on our compounds across a broad range of cancers. This includes data on avelumab, our late-stage investigational immuno-therapy, that is being developed in collaboration with Pfizer.
Here you will find all information about Merck KGaA, Darmstadt, Germany at ASCO 2016.


Facts & Figures
Facts and figures about Avelumab, urothelial bladder cancer, gastric cancer, lung cancer, Merkel cell carcinoma, mesothelioma cancer, renal cell carcinoma, Erbitux, biomarker, colorectal cancer, immuno-oncology.


Infograhics for head and neck cancer, colorectal cancer, RAS biomarker test


Our company und Pfizer
In the spirit of the concept „Together we are stronger“, our company and Pfizer had formed an immune-oncology alliance to accelerate the clinical development program for avelumab.


Latest news about our Oncology franchise and related disease information (videos, animations, images, media fact sheets, news releases)


Gangolf Schrimpf
Gangolf Schrimpf
Phone: +49 6151 72 9591
Fax: +49 6151 72-919591


Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
Merck KGaA, Darmstadt, Germany on Facebook
Merck KGaA, Darmstadt, Germany on LinkedIn